Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 19:2020:6126534.
doi: 10.1155/2020/6126534. eCollection 2020.

Extracorporeal Membrane Oxygenation in Cardiogenic Shock due to Acute Myocardial Infarction: A Systematic Review

Affiliations

Extracorporeal Membrane Oxygenation in Cardiogenic Shock due to Acute Myocardial Infarction: A Systematic Review

Marius Andrei Zavalichi et al. Biomed Res Int. .

Abstract

Background: Cardiogenic shock is associated with high mortality, despite new strategies for reperfusion therapy. Short-term circulatory support devices may provide adequate support for appropriate myocardial and organ perfusion.

Objectives: This review is aimed at evaluating the impact on survival when using venoarterial extracorporeal membrane oxygenation (V-A ECMO) in patients with cardiogenic shock due to acute myocardial infarction (AMI).

Methods: We performed a systematic review that included studies using V-A ECMO in patients with cardiogenic shock. Time on ECMO, side effects, and the number of deceased patients, transplanted or upgraded to durable assist devices were analysed. Literature search was done using PubMed/MEDLINE (inception (1969) to January 10, 2019), ProQuest (inception (January 14, 1988) to January 10, 2019), and clinicaltrials.gov (inception (September 12, 2005) to January 10, 2019), by 2 authors. This protocol is registered with PROSPERO (no. CRD42019123982).

Results: We included 9 studies with a total of 1,998 adult patients receiving V-A ECMO for AMI-induced cardiogenic shock. Survival rate varied from 30.0% to 79.2% at discharge and from 23.2% to 36.1% at 12 months. Time on ECMO varied between 1.96 and 6.0 days. Reported serious adverse events were gastrointestinal bleeding (3.6%) and peripheral complications (8.5%).

Conclusion: The use of V-A ECMO among patients with AMI-induced cardiogenic shock may provide survival benefits. However, V-A ECMO treatment effects are inconclusive because of limitations in cohort design and reporting.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Selection process of the included studies.

References

    1. Goldberg R. J., Samad N. A., Yarzebski J., Gurwitz J., Bigelow C., Gore J. M. Temporal trends in cardiogenic shock complicating acute myocardial infarction. New England Journal of Medicine. 1999;340(15):1162–1168. doi: 10.1056/NEJM199904153401504. - DOI - PubMed
    1. Goldberg R. J., Gore J. M., Thompson C. A., Gurwitz J. H. Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: the second national registry of myocardial infarction. American Heart Journal. 2001;141(1):65–72. doi: 10.1067/mhj.2001.111405. - DOI - PubMed
    1. Noc M., Radsel P. Urgent invasive coronary strategy in patients with sudden cardiac arrest. Current Opinion in Critical Care. 2008;14(3):287–291. doi: 10.1097/MCC.0b013e3282f85bb0. - DOI - PubMed
    1. Kolte D., Khera S., Aronow W. S., et al. Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. Journal of the American Heart. 2014;3(1, article e000590) doi: 10.1161/JAHA.113.000590. - DOI - PMC - PubMed
    1. Khalid L., Dhakam S. H. A review of cardiogenic shock in acute myocardial infarction. Current Cardiology Reviews. 2008;4(1):34–40. doi: 10.2174/157340308783565456. - DOI - PMC - PubMed

Publication types

MeSH terms